Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

86 results about "6-Aminocaproic Acid" patented technology

Preparation method of graphene modified nylon 6 fiber

The invention relates to a preparation method of a graphene modified nylon 6 fiber and belongs to the technical field of a functional fiber material. The preparation method comprises the following steps of: carrying out carboxylation and acylating chlorination treatment on graphene; then carrying out diamine treatment to obtain graphene oxide with an active amino on the surface; carrying out polymerization reaction by utilizing the aminated graphene and caprolactam through an initiator 6-aminocaproic acid to prepare a modified nylon 6 melt of the graphene; and carrying out spinning and stretching through a fusion and spinning process to obtain the graphene modified nylon 6 fiber. The technical scheme of the invention utilizes aminated graphene enhanced 6 to improve the interface bonding strength with a base resin, so as to be good for improving the whole performance of the graphene modified nylon 6 fiber. A fiber material prepared by the preparation method provided by the invention can be widely applied to the technical fields of aerospace, cars and ships, communication and transportation, mechano-electronics and the like.
Owner:SUZHOU UNIV

Synthesis method of specific salbutamol artificial antigen

The invention discloses a synthesis method of a specific salbutamol artificial antigen, belonging to the technical field of biological chemical engineering. The synthesis method disclosed by the invention comprises the following steps of: activating salbutamol through a formaldehyde solution, and connecting 6-aminocaproic acid in the ortho-position of a phenolic hydroxyl group to obtain a salbutamol hapten; and coupling a carboxyl group on the salbutamol hapten with an amino group on a carrier protein to obtain the salbutamol artificial antigen. The synthesis method disclosed by the invention can make up for the insufficiencies and defects of the existing salbutamol antigen synthesis technologies, the salbutamol artificial antigen with high specificity is obtained, the specificity of a produced antibody is high, and the sensitivity is high; and experimental results show that the antiserum titre of an animal immunized by using the salbutamol artificial antigen disclosed by the invention can achieve 80000, the detection limit is 0.5ng / mL, and the half-inhibitory concentration IC50 is 5ng / mL. The antigen or the antibody disclosed by the invention can be used for establishing an enzyme-linked immunosorbent analytical method and a colloidal gold test strip rapid assay method so as to rapidly detect the residues of the salbutamol in a food and further realize broad application prospects.
Owner:JIANGNAN UNIV

Lactic acid-amino acid copolyester amide and preparation method thereof

The invention relates to lactic acid-amino acid copolyester amide and a preparation method thereof and relates to the technical field of the copolyester amide. The lactic acid-amino acid copolyester amide can be used for improving thermal stability and mechanical strength of a polylactic acid material, and also can be used as a compatibilizer in the blending of polylactic acid and nylon. The lactic acid-amino acid copolyester amide is prepared by copolymerization of any amino acid and lactic acid, wherein the monomer of any amino acid can be 11-amino undecanoic acid, 12-amino dodecanoic acid and 6-aminocaproic acid or caprolactam, glycine, aminopropionic acid, aminobutyric acid, 8-aminocaprylic acid or octane lactam, 9-aminononanoic acid or nonane lactam, 10-amino decenouc acid or decane lactam, dodecane lactam, 14-amino tetradecanoic acid. According to the lactic acid-amino acid copolyester amide and the preparation method thereof disclosed by the invention, the polylactic acid products are various, the thermal performances and the mechanical performances of the polylactic acid products are improved and the application range of the material is more extensive.
Owner:盐城创咏新能源投资有限公司

Isolation and purification of 6-aminocaproic acid

The present invention relates to a new process for the isolation and purification of 6-aminocaproic acid, which is a known inhibitor of enzymes responsible for fibrinolysis and is used in the treatment of coagulopathies and severe post-operative bleedings.
Owner:DIPHARMA FRANCIS

Method for synthesis of chlorothalonil artificial antigen

The invention discloses a method for synthesis of a chlorothalonil artificial antigen and belongs to the technical field of biochemical engineering. A chlorothalonil raw drug and 6-aminocaproic acid undergo a reaction to produce hapten CTNH as a hydroxy product, the CTNH is coupled with carrier protein bovine serum albumin (BSA) by a carbodiimide method so that a conjugate CTNH-BSA is obtained and is used as an immunizing antigen, the CTNH is coupled with carrier protein chicken egg albumin (OVA) so that a conjugate CTNH-OVA is obtained and is used as a coating antigen, and conjugate coupling ratios are determined by an ultraviolet method. The method realizes successfully synthesis of the chlorothalonil artificial antigen, has simple and effective synthesis steps, can be completely used for immunization analysis and provides a necessary artificial antigen for later research.
Owner:JIANGNAN UNIV

Preparation method of 6-aminocaproic acid

The invention discloses a preparation method of 6-aminocaproic acid. The 6-aminocaproic acid is obtained by using caprolactam as a raw material through alkali hydrolysis, neutralization processing, desalination processing and refining processing; alkali hydrolysis is that the caprolactam reacts with sodium hydroxide and water for 1 to 5h at a temperature of 100 to 110 DEG C; neutralization processing is that the material obtained after alkali hydrolysis is cooled to room temperature and is neutralized into pH of 7.5 by dilute sulphuric acid; desalination processing is that the material obtained after neutralization processing is subjected to desalination of electrodialysis. According to the method disclosed by the invention, an alkali hydrolysis method is adopted, then the dilute sulphuricacid is adopted to neutralize the material obtained after alkali hydrolysis into an isoelectric point of the 6-aminocaproic acid, and electrodialysis is utilized to desalinate. The method not only isconvenient to operate and simple in reaction condition, but also does not need to adopt ion exchange resin so as to greatly reduce the defects of higher production cost, serious pollution to the environment and the like of a resin absorption method; particularly, the method is higher in yield, is basically 95% or more and is suitable for industrial mass production.
Owner:CHANGZHOU LANLING PHARMA

Synthesis method of highly specific folic acid complete antigen and application of folic acid complete antigen

The invention relates to a synthesis method of a highly specific folic acid complete antigen and an application of the folic acid complete antigen and belongs to the technical field of biochemical industry. The synthesis method disclosed by the invention comprises the steps of adding 6-aminocaproic acid and water-soluble carbodiimide into a vector protein solution and then reacting at a room temperature and carrying out dialysis to obtain a vector protein B modified by a linker arm, dissolving folic acid(N-{4-[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methylamino]benzoyl}-L-glutamic acid) in dimethyl sulfoxide, adding dicyclohexyl carbodiimide and hydroxysuccinimide, reacting to obtain a folic acid derivative and then coupling the folic acid derivative with an amino group on the linker arm of the vector protein B to obtain the complete antigen. The results show that the titer of the antiserum obtained by immunizing animals with the antigen disclosed by the invention reaches up to 81000, the detection limit is 0.042ng/mL, and the half-inhibitory concentration is 0.3ng/mL. The produced antibody has high specificity and high sensitivity. The antigen or antibody disclosed by the invention is used for preparing an immunoaffinity column, establishing an enzyme linked immunosorbent assay method and colloidal gold strip rapid detection method and detecting the residue of folic acid.
Owner:JIANGNAN UNIV

Method for preparing 6-bromotriphenylphosphonio-n-caproic acid

The invention relates to the field of production and preparation of compounds and particularly relates to a method for preparing 6-bromotriphenylphosphonio-n-caproic acid. The method comprises the following steps: (1) subjecting caprolactam to a hydrolysis reaction, so as to prepare 6-aminocaproic acid; (2) subjecting 6-aminocaproic acid to a diazotization reaction, so as to prepare 6-hydroxycaproic acid; (3) subjecting 6-hydroxycaproic acid to a bromization reaction, so as to prepare 6-bromocaproic acid; and (4) enabling 6-bromocaproic acid to react with triphenyl phosphine, thereby obtaining 6-bromotriphenylphosphonio-n-caproic acid.
Owner:黄石市利福达医药化工有限公司

Nylon 6 resin for food packaging materials as well as preparation method and application thereof

ActiveCN104356639AFavorable for solid state polymerizationReduce contentFlexible coversWrappersPolymer scienceO-Phosphoric Acid
The invention relates to nylon 6 resin for food packaging materials. The nylon 6 resin comprises the following components in part by weight: 1000 parts of ordinary nylon 6 resin, 0.6-1 part of pentaerythritol stearate, 0.5-0.8 part of erucamide, 0.3-0.8 part of phosphoric acid, 1.5-2 parts of 6 aminocaproic acid and 0.4-0.6 part of N, N'-ethylene bis stearamide. The invention simultaneously provides a preparation method and an application of the nylon 6 resin. With the adoption of the technical scheme, the nylon 6 resin as well as the preparation method and the application thereof have the advantages of high uniformity and stability in extrusion, high transparency, small haze and no spot when a biaxially-oriented nylon film is post-processed, and the cost is greatly reduced compared with that of an imported similar product.
Owner:HENGSHUI JINLUN PLASTIC

Modified enhanced corona resistant wire and preparation method thereof

The invention relates to a modified enhanced corona resistant wire and a production method thereof. The modified enhanced corona resistant wire disclosed by the embodiment of the invention consists ofa metal conductor, a first composite insulating layer and a second composite insulating layer. Compared with the prior art, the production method in the embodiment disclosed by the invention has thecharacteristics that a polyurethane composite insulating layer of which double sides are coated with polytetrafluoroethylene is used as the first composite insulating layer; a second composite insulating layer is prepared by using polytetrahydrofuran ether glycol, polyethylene glycol, polypropylene glycol, oxalic acid, epsilon-caprolactam, terephthalic acid, 6-aminocaproic acid, butyl titanate, nanometer aluminum nitride, nanometer boron nitride and nano-silica. Therefore, according to the production method of the modified enhanced corona resistant wire disclosed by the embodiment of the invention, corona resistance of the wire can be significantly improved and mechanical properties of the wire are improved, so that the wire is safer and more convenient to apply.
Owner:上海旌缘科技股份有限公司

Structural molecule for affinity and target cell uptake capability of enhanced integrin receptor and application thereof

The invention discloses a structural molecule for affinity and target cell uptake capability of enhanced integrin receptor. The structural molecule has a molecular structure shown in a formula (I); the structural molecule is obtained by carrying out reaction between two cRGD oligopeptides and 6-aminocaproic acid, glutamate oligopeptide or / and arginine oligopeptide, 8-amino-3,6-dioxaoctanoic acid or 3-maleimidopropionic acid and the like to perform dehydration condensation on amino and carboxyl. According to the structural molecule disclosed by the invention, tumor cells expressing an alpha v beta 3 receptor and neovascular endothelial cells can be specially combined, the carried molecules such as nucleotide enter cytoplasm through receptor-mediated endocytic uptake, so that the uptake efficiency of expression cells of the alpha v beta 3 receptor is improved and the release of the carried molecules from a target cytoplasm endosome is promoted, and therefore, the structural molecule can be applied to preparation of targeted therapy drugs or disease diagnosis tracer agents.
Owner:WUHAN ZEZHI BIOLOGICAL PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products